Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program
NCT ID: NCT02508597
Last Updated: 2017-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2014-08-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We designed a brief smoking cessation counselling model (AWARD) which takes only 10-20 seconds. We will train the physicians to perform the AWARD cessation counselling model in clinic, and encourage them to participate in our brief smoking cessation intervention project using the randomized controlled trail (RCT) design and to train more peer physicians to perform brief smoking cessation counseling. We propose to investigate the effect of the training program on physicians' knowledge of tobacco cessation, practice of performing cessation counselling, and attitudes toward tobacco control policies.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Goal and the details of the brief smoking counselling intervention;
* Objective of the mini TTT training program;
* Tobacco epidemic and control measures in China and the world;
* Physicians' role in tobacco control;
* Health risks of smoking, secondhand smoke exposure;
* WHO FCTC (Framework Convention on Tobacco Control) and the MPOWER measures;
* Brief smoking cessation counselling (AWARD model), and counselling skill with practice;
* Placebo counselling and counselling skill with practice.
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. The investigators will explain that the participation is totally voluntary, and the participants will be invited to complete a paper-and-pencil survey before and right after the training workshop, perform smoking cessation counselling or placebo counselling among patients at their clinics, and complete online survey at 6- and 12-month follow-up. Agreement to participate in the training program will be considered as consent and participants are required to sign a written consent form.
At the end of the workshop, participants should be confident to perform brief smoking cessation counselling and placebo counselling for patients.
We hypothesize that the training program will increase the participants' knowledge level of smoking and secondhand smoke exposure and the important role of physicians in tobacco control, increase their skill and confidence of performing smoking cessation counselling, and generate stronger support for tobacco control policies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physicians receiving smoking cessation training
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.
Physicians receiving smoking cessation training
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physicians receiving smoking cessation training
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Lam Tai-Hing
Chair Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tai Hing Lam, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
5/F William MW Mong Block, LKS Faculty of Medicine Building, 21 Sassoon Road, Pokfulam
Hong Kong, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MiniTTT
Identifier Type: -
Identifier Source: org_study_id